Clinical evidence confirmed the importance of CTLs in patients suffering from melanoma and other cancers, as infiltrating CD8+ T cells found in tumor biopsies were strongly associated with improved life expectancy (18–20). The gene discussed is CD8A; the disease is melanoma.